Open AccessPlasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment
Author(s) -
Vincenzo Spagnuolo,
Deborah Cocorullo,
Laura Galli,
Alba Bigoloni,
Andrea Galli,
Alessandro Rubinacci,
Giovanna Mignogna,
Alessia Carbone,
Adriano Lazzarin,
Antonella Castagna
Publication year - 2013
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt264
Subject(s) - osteocalcin , human immunodeficiency virus (hiv) , medicine , fibroblast growth factor 23 , risk factor , antiretroviral therapy , endocrinology , immunology , viral load , biology , biochemistry , parathyroid hormone , alkaline phosphatase , calcium , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom